MCF Advisors’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
CF
PVM
NI
MCF Advisors's HCAT Position: Q2 2026 in Review
MCF Advisors reduced its Health Catalyst (HCAT) stake by 34% in Q2 2026, selling an estimated $33.9K and leaving 46,500 shares worth $92.5K. The position accounts for ﹤0.01% of the portfolio, ranked #550.
MCF Advisors first reported a position in HCAT in Q1 2025 and has held it in 6 quarters since. The position peaked at $214K in Q3 2025. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.
- MCF Advisors held 46,500 shares of Health Catalyst worth $92.5K as of Q2 2026.
- MCF Advisors sold 23,500 Health Catalyst shares in Q2 2026, an estimated $33.9K.
- Health Catalyst made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #550 holding.
- MCF Advisors first reported a position in Health Catalyst in Q1 2025 and has held it in 6 quarters since.
- MCF Advisors's Health Catalyst position peaked at $214K in Q3 2025.
- 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.
Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.